Sorry, I had meant SIRT (rather than SRX). Furthermore, on the basis of these results (i.e., better tolerated treatment), SRX should apply for - and should get - FDA approval for SIRT, given that Sorafenib was FDA approved in 2013.
Sirt result, page-17
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $80.75K | 461.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3584834 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2522138 | 37 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |